Compare IITRI Drug Discovery Division vs Proteostasis Therapeutics
Customers evaluate the quality of IITRI Drug Discovery Division's products using the following success metrics.
Overview
IITRI Drug Discovery Division is based in United States
IIT Research Institute (IITRI) is a contract research organization (CRO) that aims to provide non-clinical toxicology and other drug development services to government and industry. IITRI offers particular expertise in oncologics drug development, inhalation toxicology and technology, carcinogenesis and cancer prevention, and biodefense. IITRI's Drug Discovery Division is a research-based group whose focus is the design and synthesis of new small molecule therapeutics for cancer and infectious disease.
Proteostasis Therapeutics is 17 yrs old and is based in United States.
Proteostasis Therapeutics (NASDAQ: PTI) develops disease-modifying therapeutics for diseases of protein processing. It provides clinical-stage novel small molecule therapies to treat the cause of cystic fibrosis. The company was founded in 2007 and is based in Boston, Massachusetts.
Demo Video
Leadership
David McCormick (President)
David D Pendergast (Founder)
Funding
Investors
New Enterprise Associates, Novartis Venture Funds
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because IITRI Drug Discovery Division has not claimed their profile.
Work for IITRI Drug Discovery Division? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for IITRI Drug Discovery Division?
Claim your profile now.
Information not available because Proteostasis Therapeutics has not claimed their profile.
Work for Proteostasis Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Proteostasis Therapeutics?
Claim your profile now.